Table 3.
Histologic abnormalities of study groups
| IBD | Control | p value | |
|---|---|---|---|
| Gastritis | 11/18 (61 %) | 4/18 (22 %) | .020 |
| Duodenitis | 4/18 (22 %) | 2/19 (11 %) | .303 |
| Lymphoid hyperplasia: duodenum | 1/18 (6 %) | 0/19 (0 %) | .486 |
| Lymphoid hyperplasia: cecum | 1/8 (13 %) | 0/4 (0 %) | .667 |
| Lymphoid hyperplasia: terminal ileum | 3/14 (21 %) | 0/11 (0 %) | .158 |
| Basal plasmacytosis: rectosigmoid | 2/15 (13 %) | 0/14 (0 %) | .259 |
| Basal plasmacytosis: transverse colon | 1/3 (33 %) | 0/4 (0 %) | .429 |
| Basal plasmacytosis: cecum | 1/8 (13 %) | 0/4 (0 %) | .667 |
| Cryptitis: colon any area | 6/37 (16 %) | 3/33 (9 %) | .485 |
| Cryptitis: duodenum | 2/18 (11 %) | 0/19 (0 %) | .230 |
| Cryptitis: rectosigmoid | 3/15 (20 %) | 1/13 (8 %) | .356 |
| Cryptitis: left colon | 0/2 (0 %) | 1/3 (33 %) | .600 |
| Cryptitis: transverse colon | 1/3 (33 %) | 1/4 (25 %) | .714 |
| Cryptitis: right colon | 1/3 (33 %) | 0/2 (0 %) | .600 |
| Cryptitis: terminal ileum | 1/14 (7 %) | 0/11 (0 %) | .560 |
| Crypt abscess: colon any area | 2/23 (9 %) | 0/18 (0 %) | .495 |
| Crypt abscess: rectosigmoid | 2/15 (13 %) | 0/14 (0 %) | .259 |
| Crypt abscess: cecum | 1/8 (13 %) | 0/4 (0 %) | .667 |
| Crypt distortion: colon any area | 10/29 (34 %) | 1/24 (4 %) | .008 |
| Crypt distortion: rectosigmoid | 2/15 (13 %) | 0/14 (0 %) | .259 |
| Crypt distortion: transverse colon | 1/3 (33 %) | 0/4 (0 %) | .429 |
| Crypt distortion: right colon | 2/3 (67 %) | 0/2 (0 %) | .300 |
| Crypt distortion: cecum | 5/8 (63 %) | 1/4 (25 %) | .273 |